BridgeBio Oncology Therap... (BBOT)
NASDAQ: BBOT
· Real-Time Price · USD
10.04
-2.04 (-16.89%)
At close: Aug 19, 2025, 11:58 AM
-16.89% (1D)
| Bid | 8.7 |
| Market Cap | 795.13M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -1.02 |
| PE Ratio (ttm) | -9.84 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 12.5 |
| Volume | 80,685 |
| Avg. Volume (20D) | 91,658 |
| Open | 11.98 |
| Previous Close | 12.08 |
| Day's Range | 9.65 - 12.50 |
| 52-Week Range | 8.50 - 12.50 |
| Beta | n/a |
About BBOT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BBOT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BBOT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts20 hours ago
+13.43%
BridgeBio Oncology Therapeutics shares are trading...
Unlock content with
Pro Subscription